Mechanism-Driven Repurposing of All-Trans Retinoic Acid (ATRA) for AML1-MTG16⁺ Acute Myeloid Leukemia: A First-in-Human Case Report and Translational Roadmap to Overcome the “Long-Tail” Barrier

Clinical Therapeutics 2026

View at publisher

Authors: Kuangguo Zhou, Zhiqiong Wang, Jie Xiong, Wei Huang

DOI: 10.1016/j.clinthera.2026.03.015

Cited by: 1

References: 14

Fields of Study & Subjects

Acute Myeloid Leukemia Research Retinoids in leukemia and cellular processes Acute Lymphoblastic Leukemia research

References 14